Z79.622
Billable
ChapterZ00–Z99
Ranksubcategory
Official Description
Long term (current) use of Janus kinase inhibitor
Metadata & Insights
- •Billable/specific code (valid for reimbursement).
- •Chapter 21: Factors Influencing Health Status and Contact with Health Services (Z00-Z99).
Instructional Notes
Includes
- Long term (current) use of tofacitinib
General instructions are available for the parent sections:
Clinical Hierarchy
BillableHas subcodes
CH21Factors influencing health status and contact with health services (Z00-Z99)
Z77-Z99Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Z79Long term (current) drug therapy
Z79.6Long term (current) use of immunomodulators and immunosuppressants
Z79.62Long term (current) use of immunosuppressant
Z79.622Long term (current) use of Janus kinase inhibitorBillable
Applicable Ancestor Context
The following parent sections contain instructions or notes that apply to Z79.622:
subcategoryZ79.6
Long term (current) use of immunomodulators and immunosuppressants
View context instructionsblockZ77-Z99
Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
View context instructionsCode History
- FY 2022: This code replaced Z79.899 (Other long term (current) drug therapy)
MS-DRG Classification
This code is grouped within the following Diagnosis Related Group(s) for clinical reimbursement:
Cross Reference
Find Procedures (ICD-10-PCS)
Find surgical and procedural codes related to Long term (current) use of Janus kinase inhibitor.
Search PCS Codes